Document:

Exhibit 4.2

 

SUBSCRIPTION AGREEMENT

 

SUBSCRIPTION AGREEMENT (this
“Agreement”) made as of the last date set forth on the signature page hereof between Avalon GloboCare Corp., a Delaware
corporation (the “Company”), and the undersigned (the “Subscriber”).

 

W I T N E S S E T H:

 

WHEREAS, the Company is conducting
a private offering (the “Offering”) consisting of 320,513 shares (the “Shares”) of common stock,
$0.0001 par value per share (“Common Stock”), pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the “Securities Act”) and/or Rule 506 promulgated thereunder; and

 

WHEREAS, the Subscriber desires
to purchase that number of Shares set forth on the signature page hereof on the terms and conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration
of the premises and the mutual representations and covenants hereinafter set forth, the parties hereto do hereby agree as follows:

 

	I.	SUBSCRIPTION FOR SHARES AND REPRESENTATIONS AND COVENANTS BY SUBSCRIBER

 

1.1   Subject
to the terms and conditions hereinafter set forth, the Subscriber hereby irrevocably subscribes for and agrees to purchase from the Company
such number of Shares, and the Company agrees to sell to the Subscriber as is set forth on the signature page hereof, at a per share price
equal to $0.78 per Share.

 

1.2   The
Subscriber recognizes that the purchase of the Shares involves a high degree of risk including, but not limited to, the following: (a)
the Company has limited operating history and requires substantial funds in addition to the proceeds of the Offering; (b) an investment
in the Company is highly speculative, and only investors who can afford the loss of their entire investment should consider investing
in the Company and the Shares; (c) the Subscriber may not be able to liquidate its investment; (d) transferability of the Shares is extremely
limited; (e) in the event of a disposition, the Subscriber could sustain the loss of its entire investment; (f) the Company has not paid
any dividends since its inception and does not anticipate paying any dividends; (g) the Company may issue additional securities in the
future which have rights and preferences that are senior to those of the Common Stock and (h) the additional risk factors set forth in
the Company’s filings with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Without
limiting the generality of the representations set forth in Section 1.5 below, the Subscriber represents that the Subscriber has carefully
reviewed the risk factors described in the Company’s filings made under the Securities Exchange Act of 1934, as amended.

 

    1

     

    

 

1.3   The
Subscriber has carefully read the Form 8-Ks Current Report as filed with the Securities and Exchange Commission (the “SEC”)
on July 27, 2022, June 8, 2022 and May 23, 2022 (the “8Ks”), Form 10-Q Quarterly Report for the quarter ended March 31,
2022 as filed with the SEC on May 11, 2022 (the “10Q”) and the Form 10-K Annual Report for the year ended December 31,
2021 as filed with the SEC on March 30, 2022 (“10K” together with the 8Ks and the 10Q, the “Reports”)
as well as all other filings made by the Company with the SEC including the risk factors contained in the Reports (the “Risk
Factors”). The Subscriber has been given the opportunity to ask questions of, and receive answers from, the Company concerning
the terms and conditions of this Offering, the Reports and the Risk Factors and to obtain such additional information, to the extent the
Company possesses such information or can acquire it without unreasonable effort or expense, necessary to verify the accuracy of same
as the Subscriber reasonably desires in order to evaluate the investment. The Subscriber understands the Reports and the associated Risk
Factors, and the Subscriber has had the opportunity to discuss any questions regarding any of the disclosure in the Reports and the associated
Risk Factors with his counsel or other advisor. Notwithstanding the foregoing, the only information upon which the Subscriber has relied
is that set forth in the Reports and the associated Risk Factors. The Subscriber has received no representations or warranties from the
Company, its employees, agents or attorneys, in making this investment decision other than as set forth in the Reports and the associated
Risk Factors.

 

1.4   The
Subscriber represents that the Subscriber is an “accredited investor” as such term is defined in Rule 501 of Regulation D
(“Regulation D”) promulgated under the Securities Act and that the Subscriber is able to bear the economic risk of
an investment in the Shares.

 

1.5   The
Subscriber hereby acknowledges and represents that (a) the Subscriber has knowledge and experience in business and financial matters,
prior investment experience, including investment in securities that are thinly traded or the Subscriber has employed the services of
a “purchaser representative” (as defined in Rule 501 of Regulation D), attorney and/or accountant to read all of the documents
furnished or made available by the Company both to the Subscriber and to all other prospective investors in the Shares to evaluate the
merits and risks of such an investment on the Subscriber’s behalf; (b) the Subscriber recognizes the highly speculative nature of
this investment; and (c) the Subscriber is able to bear the economic risk that the Subscriber hereby assumes.

 

1.6   The
Subscriber hereby acknowledges receipt and careful review of this Agreement, including all exhibits thereto, and any documents which may
have been made available upon request as reflected therein (collectively referred to as the “Offering Materials”) and
hereby represents that the Subscriber has been furnished by the Company during the course of the Offering with all information regarding
the Company, the terms and conditions of the Offering and any additional information that the Subscriber has requested or desired to know,
and has been afforded the opportunity to ask questions of and receive answers from duly authorized officers or other representatives of
the Company concerning the Company and the terms and conditions of the Offering.

 

 1.7 (a) In making the decision to invest
in the Shares the Subscriber has relied solely upon the information provided by the Company in the Offering Materials. To the extent necessary,
the Subscriber has retained, at its own expense, and relied upon appropriate professional advice regarding the investment, tax and legal
merits and consequences of this Agreement and the purchase of the Shares hereunder. The Subscriber disclaims reliance on any statements
made or information provided by any person or entity in the course of Subscriber’s consideration of an investment in the Shares
other than the Offering Materials.

 

    2

     

    

 

(b)   The
Subscriber represents that (i) the Subscriber was contacted regarding the sale of the Shares by the Company (or an authorized agent or
representative thereof) with whom the Subscriber had a prior substantial pre-existing relationship and (ii) no Shares were offered or
sold to it by means of any form of general solicitation or general advertising, and in connection therewith, the Subscriber did not (A)
receive or review any advertisement, article, notice or other communication published in a newspaper or magazine or similar media or broadcast
over television or radio, whether closed circuit, or generally available; or (B) attend any seminar meeting or industry investor conference
whose attendees were invited by any general solicitation or general advertising.

 

1.8   The
Subscriber hereby represents that the Subscriber, either by reason of the Subscriber’s business or financial experience or the business
or financial experience of the Subscriber’s professional advisors (who are unaffiliated with and not compensated by the Company
or any affiliate or selling agent of the Company, directly or indirectly), has the capacity to protect the Subscriber’s own interests
in connection with the transaction contemplated hereby.

 

1.9   The
Subscriber hereby acknowledges that the Offering has not been reviewed by the SEC nor any state regulatory authority since the Offering
is intended to be exempt from the registration requirements of Section 5 of the Securities Act, pursuant to Regulation D. The Subscriber
understands that the Shares have not been registered under the Securities Act or under any state securities or “blue sky”
laws and agrees not to sell, pledge, assign or otherwise transfer or dispose of the Shares unless they are registered under the Securities
Act and under any applicable state securities or “blue sky” laws or unless an exemption from such registration is available.

 

1.10   The
Subscriber understands that the Shares have not been registered under the Securities Act by reason of a claimed exemption under the provisions
of the Securities Act that depends, in part, upon the Subscriber’s investment intention. In this connection, the Subscriber hereby
represents that the Subscriber is purchasing the Shares for the Subscriber’s own account for investment and not with a view toward
the resale or distribution to others. The Subscriber, if an entity, further represents that it was not formed for the purpose of purchasing
the Shares.

 

1.11   The
Subscriber understands that the common stock issuable upon conversion of the Common Stock is quoted on the OTC Markets and that there
is a limited market for the Common Stock. The Subscriber understands that even if a public market develops for the Common Stock, Rule
144 (“Rule 144”) promulgated under the Securities Act requires for non-affiliates, among other conditions, a holding
period prior to the resale (in limited amounts) of securities acquired in a non-public offering without having to satisfy the registration
requirements under the Securities Act. The Subscriber understands and hereby acknowledges that the Company is under no obligation to register
any of the Shares under the Securities Act or any state securities or “blue sky” laws. The Subscriber understands that the
Company must be current under the 1934 Act for the Subscriber to take advantage of Rule 144.

 

    3

     

    

 

1.12
Intentionally Left Blank.

 

1.13   The
Subscriber consents to the placement of a legend on any certificate or other document evidencing the Shares and any shares of common stock
issuable upon conversion of the Common Stock that such securities have not been registered under the Securities Act or any state securities
or “blue sky” laws and setting forth or referring to the restrictions on transferability and sale thereof contained in this
Agreement. The Subscriber is aware that the Company will make a notation in its appropriate records with respect to the restrictions on
the transferability of such Shares. The legend to be placed on each certificate shall be in form substantially similar to the following:

 

“THE SHARES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY
STATE SECURITIES OR “BLUE SKY LAWS,” AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED ABSENT AN
EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE COMPANY HAS RECEIVED
AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.THE SHARES
REPRESENTED BY THIS CERTIFICATE MAY NOT BE OFFERED, SOLD, PLEDGED, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF EXCEPT IN ACCORDANCE
WITH THE REQUIREMENTS OF THAT CERTAIN SUBSCRIPTION AGREEMENT DATED AS OF AUGSUT __, 2022, A COPY OF WHICH AGREEMENT THE COMPANY WILL FURNISH,
WITHOUT CHARGE, TO THE HOLDER OF THIS CERTIFICATE UPON WRITTEN REQUEST THEREFOR.”

 

The Company, at its discretion, may cause a stop
transfer order to be placed with its transfer agent(s) with respect to the certificates representing the Shares.

 

1.14   The
Subscriber understands that the Company will review this Agreement and is hereby given authority by the Subscriber to call Subscriber’s
bank or place of employment or otherwise review the financial standing of the Subscriber; and it is further agreed that the Company, at
its sole discretion, reserves the unrestricted right, without further documentation or agreement on the part of the Subscriber, to reject
or limit any subscription, to accept subscriptions for fractional Shares and to close the Offering to the Subscriber at any time and that
the Company will issue stop transfer instructions to its transfer agent with respect to such Shares.

 

1.15   The
Subscriber hereby represents that the address of the Subscriber furnished by Subscriber on the signature page hereof is the Subscriber’s
principal residence if Subscriber is an individual or its principal business address if it is a corporation or other entity.

 

1.16   The
Subscriber represents that the Subscriber has full power and authority (corporate, statutory and otherwise) to execute and deliver this
Agreement and to purchase the Shares. This Agreement constitutes the legal, valid and binding obligation of the Subscriber, enforceable
against the Subscriber in accordance with its terms.

 

1.17   If
the Subscriber is a corporation, partnership, limited liability company, trust, employee benefit plan, individual retirement account,
Keogh Plan, or other tax-exempt entity, it is authorized and qualified to invest in the Company and the person signing this Agreement
on behalf of such entity has been duly authorized by such entity to do so.

 

    4

     

    

 

1.18   The
Subscriber acknowledges that he, she or it are not Registered Representative of a FINRA member firm or a FINRA firm.

 

1.19   The
Subscriber acknowledges that at such time, if ever, as the Shares are registered, sales of the Shares will be subject to state securities
laws.

 

1.20   The
Subscriber agrees not to issue any public statement with respect to the Subscriber’s investment or proposed investment in the Company
or the terms of any agreement or covenant between them and the Company without the Company’s prior written consent, except such
disclosures as may be required under applicable law or under any applicable order, rule or regulation.

 

1.21   The
Subscriber agrees to hold the Company and its directors, officers, employees, affiliates, controlling persons and agents and their respective
heirs, representatives, successors and assigns harmless and to indemnify them against all liabilities, costs and expenses incurred by
them as a result of (a) any sale or distribution of the Shares by the Subscriber in violation of the Securities Act or any applicable
state securities or “blue sky” laws; or (b) any false representation or warranty or any breach or failure by the Subscriber
to comply with any covenant made by the Subscriber in this Agreement (including the Confidential Investor Questionnaire contained in Article
VI herein) or any other document furnished by the Subscriber to any of the foregoing in connection with this transaction.

 

	II.	REPRESENTATIONS BY AND COVENANTS OF THE COMPANY

 

The Company hereby represents
and warrants to the Subscriber that:

 

2.1   Organization
and Qualification. The Company and each of its Subsidiaries, if any, is a corporation duly organized, validly existing and in good
standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate and other) to own, lease,
use and operate its properties and to carry on its business as and where now owned, leased, used, operated and conducted. “Subsidiary”
shall mean any corporation or other entity of which at least a majority of the securities or other ownership interests having ordinary
voting power (absolutely or contingently) for the election of directors or other persons performing similar functions are at the time
owned directly or indirectly by the Company and/or any of its other Subsidiaries.

 

2.2   Capitalization.
The authorized, issued and outstanding capital stock of the Company is as set forth in the Reports.

 

2.3   Authorization;
Enforcement. The Company has all requisite corporate power and authority to enter into and perform this Agreement.

 

2.4   Acknowledgment
of Dilution. The Company understands and acknowledges the dilutive effect to the Common Stock upon the issuance of the Shares.

 

    5

     

    

 

2.5   Bad
Actor Representation. None of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other
officer of the Company participating in the Offering, any beneficial owner of 20% or more of the Company’s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected
with the Company in any capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer Covered
Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the
Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The
Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.

 

2.6   Actions
Pending. Except as disclosed in the Reports, there is no action, suit, claim, investigation, arbitration, alternate dispute resolution
proceeding or any other proceeding pending or, to the knowledge of the Company, threatened against or involving the Company, any Subsidiary
(i) which questions the validity of this Agreement or any of the other Offering Materials or the transactions contemplated hereby or thereby
or any action taken or to be taken pursuant hereto or thereto or (ii) involving any of their respective properties or assets. To the knowledge
of the Company, there are no outstanding orders, judgments, injunctions, awards or decrees of any court, arbitrator or governmental or
regulatory body against the Company or any Subsidiary or any of their respective executive officers or directors in their capacities as
such.

 

2.7   Compliance
with Law. The Company and its Subsidiaries have all material franchises, permits, licenses, consents and other governmental or regulatory
authorizations and approvals necessary for the conduct of their respective business as now being conducted by it unless the failure to
possess such franchises, permits, licenses, consents and other governmental or regulatory authorizations and approvals, individually or
in the aggregate, could not reasonably be expected to have a Material Adverse Effect.

 

2.8   Compliance.
The Company: (i) is not in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse
of time or both, would result in a default by the Company), nor has the Company received notice of a claim that it is in default under
or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or
by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any
judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute,
rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating
to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except
in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

    6

     

    

 

2.9   No
Violation. The business of the Company and any Subsidiary is not being conducted in violation of any federal, state, local or foreign
governmental laws, or rules, regulations and ordinances of any governmental entity, except for possible violations which singularly or
in the aggregate could not reasonably be expected to have a Material Adverse Effect. The Company is not required under federal, state,
local or foreign law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any
court or governmental agency in order for it to execute, deliver or perform any of its obligations under the Offering Materials, or issue
and sell the Common Stock in accordance with the terms hereof or thereof (other than (x) any consent, authorization or order that has
been obtained as of the date hereof, (y) any filing or registration that has been made as of the date hereof or (z) any filings which
may be required to be made by the Company with the SEC or state securities administrators subsequent to each closing).

 

2.10   No
Conflicts. The execution, delivery and performance of this Agreement and the Offering Materials by the Company and the consummation
by the Company of the transactions contemplated herein and therein do not and will not (i) violate any provision of the Articles or Bylaws,
(ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, mortgage, deed of trust, indenture,
note, bond, license, lease agreement, instrument or obligation to which the Company or any Subsidiary is a party or by which it or its
properties or assets are bound, (iii) create or impose a lien, mortgage, security interest, pledge, charge or encumbrance (collectively,
“Lien”) of any nature on any property of the Company or any Subsidiary under any agreement or any commitment to which
the Company or any Subsidiary is a party or by which the Company, or any Subsidiary is bound or by which any of its respective properties
or assets are bound, or (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment
or decree (including federal and state securities laws and regulations) applicable to the Company or any Subsidiary or by which any property
or asset of the Company, or any Subsidiary are bound or affected, provided, however, that, excluded from the foregoing in
all cases are such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually
or in the aggregate, have a Material Adverse Effect.

 

2.11   Private
Placement and Solicitation. Assuming the accuracy of the Subscribers’ representations and warranties set forth in Section 1,
no registration under the Securities Act is required for the offer and sale of the Common Stock by the Company to the Subscribers as contemplated
hereby. Based in part on the accuracy of the representations of the Subscribers in Section 1, and subject to timely applicable Form D
filings pursuant to Regulation D of the Securities Act with the SEC and pursuant to applicable state securities laws, the offer, sale
and issuance of the Common Stock to be issued pursuant to and in conformity with the terms of this Agreement, will be issued in compliance
with all applicable federal and state securities laws. Neither the Company nor any of its affiliates, nor any person acting on its or
their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities
Act) in connection with the offer or sale of any of the Common Stock.

 

2.12   Governmental
Approvals. Except for the filing of any notice prior or subsequent to each closing that may be required under applicable state and/or
federal securities laws (which if required, shall be filed on a timely basis), including the filing of a Form D, no authorization, consent,
approval, license, exemption of, filing or registration with any court or governmental department, commission, board, bureau, agency or
instrumentality, domestic or foreign, is or will be necessary for, or in connection with, the execution or delivery of the Common Stock,
or for the performance by the Company of its obligations under this Agreement and the Offering Materials.

 

    7

     

    

 

2.13   Investment
Company. The Company is not an “investment company” within the meaning of such term under the Investment Company Act of
1940, as amended, and the rules and regulations of the SEC thereunder.

 

2.14   Use
of Proceeds. The Company shall use the proceeds from the sale of the Common Stock for working capital purposes and shall not, directly
or indirectly, use such proceeds for any distribution or dividend to any shareholder of the Company.

 

2.15   Securities
Compliance. The Company shall notify the SEC in accordance with its rules and regulations, of the transactions contemplated by this
Agreement and the Offering Materials, including filing a Form D with respect to the Common Stock, as required under Regulation D and applicable
“blue sky” laws if such Common Stock is offered pursuant to Rule 506 of Regulation D and shall take all other necessary action
and proceedings as may be required and permitted by applicable law, rule and regulation, for the legal and valid issuance of the Common
Stock to the Subscribers.

 

2.16   No
Integrated Offerings. The Company shall not make any offers or sales of any security (other than the securities being offered or sold
hereunder) under circumstances that would require registration of the securities being offered or sold hereunder under the Securities
Act.

 

	III.	TERMS OF SUBSCRIPTION

 

3.1   All
funds shall be submitted directly to the Company’s account identified in Section 1.1 hereof.

 

3.2   Certificates
representing the Common Stock purchased by the Subscriber pursuant to this Agreement will be prepared for delivery to the Subscriber within
15 business days following the closing, the timing of which is at the Company’s sole discretion, at which such purchase takes place.
The Subscriber hereby authorizes and directs the Company to deliver the certificates representing the Common Stock purchased by the Subscriber
pursuant to this Agreement directly to the Subscriber’s residential or business address indicated on the signature page hereto.

 

	IV.	CONDITIONS TO OBLIGATIONS OF THE SUBSCRIBERS

 

4.1   The
Subscriber’s obligation to purchase the Shares at the closing at which such purchase is to be consummated is subject to the fulfillment
on or prior to such closing of the following conditions, which conditions may be waived at the option of each Subscriber to the extent
permitted by law:

 

(a)   Covenants.
All covenants, agreements and conditions contained in this Agreement to be performed by the Company on or prior to the date of such closing
shall have been performed or complied with in all material respects.

 

    8

     

    

 

(b)   No
Legal Order Pending. There shall not then be in effect any legal or other order enjoining or restraining the transactions contemplated
by this Agreement.

 

(c)   No
Law Prohibiting or Restricting Such Sale. There shall not be in effect any law, rule or regulation prohibiting or restricting such
sale or requiring any consent or approval of any person, which shall not have been obtained, to issue the Shares (except as otherwise
provided in this Agreement).

 

	V.	MISCELLANEOUS

 

5.1   Any
notice or other communication given hereunder shall be deemed sufficient if in writing and sent by registered or certified mail, return
receipt requested, or delivered by hand against written receipt therefor, addressed as follows:

 

if to the Company,
to it at:

 

	Avalon GloboCare Corp.
	4400 Route 9 South, Suite 3100
	Freehold, New Jersey 07728
	Attention: David Jin

 

if to the Subscriber, to the Subscriber’s
address indicated on the signature page of this Agreement.

 

Notices shall be deemed to have been given or
delivered on the date of mailing, except notices of change of address, which shall be deemed to have been given or delivered when received.

 

5.2   Except
as otherwise provided herein, this Agreement shall not be changed, modified or amended except by a writing signed by the parties to be
charged, and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party
to be charged.

 

5.3   Subject
to the provisions of Section 5.10, this Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective
heirs, legal representatives, successors and assigns. This Agreement sets forth the entire agreement and understanding between the parties
as to the subject matter hereof and merges and supersedes all prior discussions, agreements and understandings of any and every nature
among them.

 

5.4   Upon
the execution and delivery of this Agreement by the Subscriber, this Agreement shall become a binding obligation of the Subscriber with
respect to the purchase of Shares as herein provided, subject, however, to the right hereby reserved by the Company to enter into the
same agreements with other subscribers and to add and/or delete other persons as subscribers.

 

    9

     

    

 

5.5   NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT ALL THE TERMS AND PROVISIONS
HEREOF SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW JERSEY WITHOUT REGARD TO SUCH STATE’S
PRINCIPLES OF CONFLICTS OF LAW. IN THE EVENT THAT A JUDICIAL PROCEEDING IS NECESSARY, THE SOLE FORUM FOR RESOLVING DISPUTES ARISING OUT
OF OR RELATING TO THIS AGREEMENT IS THE COURTS STATE OF NEW JERSEY IN AND FOR THE COUNTY OF MONMOUTH OR THE FEDERAL COURTS FOR SUCH STATE
AND COUNTY, AND ALL RELATED APPELLATE COURTS, THE PARTIES HEREBY IRREVOCABLY CONSENT TO THE JURISDICTION OF SUCH COURTS AND AGREE TO SAID
VENUE.

 

5.6   In
order to discourage frivolous claims the parties agree that unless a claimant in any proceeding arising out of this Agreement succeeds
in establishing his claim and recovering a judgment against another party (regardless of whether such claimant succeeds against one of
the other parties to the action), then the other party shall be entitled to recover from such claimant all of its/their reasonable legal
costs and expenses relating to such proceeding and/or incurred in preparation therefor.

 

5.7   The
holding of any provision of this Agreement to be invalid or unenforceable by a court of competent jurisdiction shall not affect any other
provision of this Agreement, which shall remain in full force and effect. If any provision of this Agreement shall be declared by a court
of competent jurisdiction to be invalid, illegal or incapable of being enforced in whole or in part, such provision shall be interpreted
so as to remain enforceable to the maximum extent permissible consistent with applicable law and the remaining conditions and provisions
or portions thereof shall nevertheless remain in full force and effect and enforceable to the extent they are valid, legal and enforceable,
and no provisions shall be deemed dependent upon any other covenant or provision unless so expressed herein.

 

5.8   It
is agreed that a waiver by either party of a breach of any provision of this Agreement shall not operate, or be construed, as a waiver
of any subsequent breach by that same party.

 

5.9   The
parties agree to execute and deliver all such further documents, agreements and instruments and take such other and further action as
may be necessary or appropriate to carry out the purposes and intent of this Agreement.

 

5.10   This
Agreement may be executed in two or more counterparts each of which shall be deemed an original, but all of which shall together constitute
one and the same instrument.

 

5.11   Nothing
in this Agreement shall create or be deemed to create any rights in any person or entity not a party to this Agreement.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    10

     

    

 

NUMBER OF SHARES 320,513
X $0.78 = $250,000 (the “Purchase Price”) 

 

	 	 	 
	Signature	 	Signature (if purchasing jointly)
	 	 	 
	Emma Li Xu, Qingbo	 	 
	Name Typed or Printed	 	Name Typed or Printed
	 	 	 
	 	 	 
	Title (if Subscriber is an Entity)	 	Title (if Subscriber is an Entity)
	 	 	 
	 	 	 
	Entity Name (if applicable)	 	Entity Name (if applicable
	 	 	 
	 	 	 
	 	 	 
	3 Pine Drive	 	 
	Address	 	Address
	 	 	 
	ColdSpring Har,NY, 11724	 	 
	City, State and Zip Code	 	City, State and Zip Code
	 	 	 
	 	 	 
	Telephone-Business	 	Telephone-Business
	 	 	 
	 	 	 
	Telephone-Residence	 	Telephone-Residence
	 	 	 
	 	 	 
	Facsimile-Business	 	Facsimile-Business
	 	 	 
	 	 	 
	Facsimile-Residence	 	Facsimile-Residence
	 	 	 
	 	 	 
	Tax ID # or Social Security #	 	Tax ID # or Social Security # 

 

	Name in which securities should be issued:	 	Emma Li
    Xu, Qingbo

 

Dated: August 5, 2022

 

This Subscription Agreement is agreed to and
accepted as of August 5, 2022.

 

	 	AVALON GLOBOCARE CORP.
	 	 	 	 
	 	By:	 
	 	 	Name: 	David Jin
	 	 	Title:	Chief Executive Officer 

 

 

11Exhibit 4.1

    

   

    
    THE INDEBTEDNESS EVIDENCED BY THIS NOTE (AS DEFINED BELOW) IS SUBORDINATE TO THE INDEBTEDNESS OF SANUWAVE HEALTH, INC. (OR ANY SUCCESSOR THERETO) TO
      NH EXPANSION CREDIT FUND HOLDINGS LP, TO THE EXTENT AND PURSUANT TO THE TERMS OF THAT CERTAIN SUBORDINATION AGREEMENT, DATED AS OF AUGUST 5, 2022, BY AND AMONG NH EXPANSION CREDIT FUND HOLDINGS LP AND THE PARTIES IDENTIFIED ON THE SIGNATURE PAGES
      THERETO, AS AMENDED, RESTATED, SUPPLEMENTED OR OTHERWISE MODIFIED FROM TIME TO TIME (OR ANY SUCCESSOR AGREEMENT WHICH REPLACES AND REFERENCES SUCH AGREEMENT).

    

    

    NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS NOTE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN
      REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
      UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL SELECTED BY THE HOLDER, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT, OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
      NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. ANY TRANSFEREE OF THIS NOTE SHOULD CAREFULLY REVIEW THE TERMS OF THIS NOTE.
      THE PRINCIPAL AMOUNT REPRESENTED BY THIS NOTE AND, ACCORDINGLY, THE SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF.

    

    

    SANUWAVE HEALTH, INC.

    

    

    FUTURE ADVANCE CONVERTIBLE PROMISSORY NOTE

    

    

    	
            Issuance Date: August 5, 2022

          	
                                         Principal Amount: Up to U.S. $[●]

          

    

    

    FOR VALUE RECEIVED, SANUWAVE
        Health, Inc., a corporation organized under the laws of Nevada (the “Company”), pursuant to this Future Advance Convertible Promissory Note (this “Note”) hereby promises to pay to          , its designee or registered assigns (the “Holder”) in cash and/or in shares of Common
        Stock (as defined in Section 26) the principal amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the “Principal”) as may be
        advanced in disbursements (each, a “Disbursement” and together, the “Disbursements” with total principal
        of outstanding Disbursements equaling Principal), and to pay interest at a rate of fifteen percent (15%) per annum (“Interest”) on any outstanding Principal at the applicable
        Interest Rate from the date of this Note until the Note is accelerated, converted, redeemed or otherwise (in each case in accordance with the terms hereof). Certain capitalized terms used herein are defined in Section 26. This Note is issued
        pursuant to that certain Securities Purchase Agreement, dated August 5, 2022, by and among the Company and the parties
          identified on the signature pages thereto (the “Purchase Agreement”), and capitalized terms not defined herein will have the meanings set forth in the Purchase
        Agreement.

    

    

    (1) PAYMENTS OF PRINCIPAL; PREPAYMENT. On the Disbursement Maturity Date, the Company
      shall pay to the Holder the applicable principal amount of the Disbursement in cash and/or shares of Common Stock and accrued and unpaid Interest on such Disbursement’s Principal and Interest.

     

    

    
      
        

    

    
    (2) INTEREST. Interest for each of the Disbursements under this Note shall commence
      accruing on the date hereof at the Interest Rate and shall be computed on the basis of a 360-day year and twelve 30-day months.  Accrued and unpaid Interest shall be payable on the Disbursement Maturity Date in cash by wire transfer of immediately
      available funds pursuant to wire instructions provided by the Holder in writing to the Company, shares of Common Stock or a combination thereof at the Holder’s discretion and if such date falls on a Holiday, the next day that is not a Holiday, to the
      record holder of this Note. Prior to the payment of Interest, Interest on this Note shall accrue at the Interest Rate and be payable by way of inclusion of the Interest in the Conversion Amount (as defined in Section 3(b)(i)).

    

    

    (3) CONVERSION OF NOTE. Following the Issuance Date, as set out above, this Note shall be
      convertible into shares of Common Stock on the terms and conditions set forth in this Section 3.

    

    

    (a) Optional Conversion Right. Subject to the provisions of Section 3(d), at any time or
      times on or after the Issuance Date of this Note, the Holder shall be entitled to convert any portion of the outstanding and unpaid Conversion Amount into fully paid and nonassessable shares of Common Stock in accordance with Section 3(c), at the
      Conversion Rate (as defined below). The Company shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share of Common Stock, the Company shall round such fraction
      of a share of Common Stock up to the nearest whole share. The Company shall pay any and all transfer, stamp and similar taxes that may be payable with respect to the issuance and delivery of Common Stock upon conversion of any Conversion Amount. The
      Holder shall have the right to deliver an effective conversion notice in the form attached hereto as Exhibit I (each, a “Conversion Notice”)

      at any time until 11:59 p.m. (EST) on the chosen date and it shall be immediately effective.

    

    

    (b) Conversion Rate. The number of shares of Common Stock issuable upon conversion of any
      Conversion Amount pursuant to Section 3(a) shall be determined by dividing (x) such Conversion Amount by (y) the Conversion Price (the “Conversion Rate”).

    

    

    (i) “Conversion Amount” means the sum of (A) the portion
      of the Principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid Interest with respect to such Principal.

    

    

    (ii) “Conversion Price” shall be equal to $0.04, as
      adjusted pursuant to the terms of this Note.

    

    

    (c) Mechanics of Optional Conversion and Adjustment:

    

    

    (i)          Registration; Book-Entry. The Company shall maintain a register (the “Register”) for the recordation of the holder of
          the Note and the Principal amount of the Note (and stated interest thereon) held by the Holder (the “Registered Note”). The entries in the Register, made in good faith, shall
          be conclusive and binding for all purposes absent manifest error. The Company and the Holder shall treat each Person whose name is recorded in the Register as the owner of the Note for all purposes, including, without limitation, the right to
          receive payments of Principal and Interest, if any, hereunder, notwithstanding notice to the contrary. Upon its receipt of a request to assign or sell all or part of the Registered Note by the Holder, the Company shall record the information
          contained therein in the Register and issue one or more new Registered Notes in the same aggregate Principal amount as the Principal amount of the surrendered Registered Note to the designated assignee or transferee pursuant to Section 14.
          Notwithstanding anything to the contrary in this Section 3(c)(i), the Holder may assign any Note or any portion thereof to an Affiliate of such Holder or a Related Fund of such Holder without delivering a request to assign or sell such Note to
          the Company and the recordation of such assignment or sale in the Register; provided, that (x) the Company may continue to deal solely with such assigning or selling Holder unless and
          until such Holder has delivered a request to assign or sell such Note or portion thereof to the Company for recordation in the Register; (y) the failure of such assigning or selling Holder to deliver a request to assign or sell such Note or
          portion thereof to the Company shall not affect the legality, validity, or binding effect of such assignment or sale and (z) such assigning or selling Holder shall, acting solely for this purpose as a non-fiduciary agent of the Company, maintain
          a register (the “Related Party Register”) comparable to the Register on behalf of the Company, and any such assignment or sale shall be effective upon recordation of such
          assignment or sale in the Related Party Register. Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Note in accordance with the terms hereof, the Holder shall not be required to physically surrender
          this Note to the Company unless the Holder has provided the Company with prior written notice (which notice may be included in a Conversion Notice) requesting reissuance of this Note upon physical surrender of this Note. The Holder and the
          Company shall maintain records showing the Principal and Interest converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as not to require physical surrender of this
          Note upon conversion.

    

    

    
      2

      
        

    

    (ii) Registration Rights. This Note is issued pursuant to the terms
      of that certain Registration Rights Agreement dated August 5, 2022, by and among the Company, the Holder and the other parties thereto (the “Registration Rights Agreement”).

    

    

    (iii) Optional Repayment (“Optional Redemption”). At the Company’s option and upon thirty (30) days’ notice to the Holder (the “Optional Redemption Notice”), the Note may be redeemed at any time at an amount equal to one hundred and twenty-five percent (125%) of the outstanding Principal and accrued and unpaid Interest (the “Optional Redemption Price”). Such notice shall specify the date of such Optional Redemption (the “Optional Redemption
        Date”). The foregoing notwithstanding, the Holder may convert any or all of this Note into shares of Common Stock pursuant to the terms of this Section 3 at any time the Note remains outstanding.

    

    

    (d) Limitations on Conversions.

    

    

    (i) Beneficial Ownership. Notwithstanding anything to the contrary
      contained in this Note, this Note shall not be convertible by the Holder hereof, and the Company shall not effect any conversion of this Note or otherwise issue any shares of Common Stock pursuant hereto, to the extent (but only to the extent) that
      after giving effect to such conversion or other share issuance hereunder the Holder (together with the Holder’s Affiliates, and any other Persons acting as a Group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)) would beneficially own in excess of 4.99% (or upon election of the Holder, 9.99%) (the “Maximum

        Percentage”) of the Common Stock. To the extent the above limitation applies, the determination of whether this Note shall be convertible (vis-à-vis other convertible, exercisable or exchangeable securities owned by the Holder and its
      Affiliates and Attribution Parties) shall, subject to such Maximum Percentage limitation, be determined on the basis of the first submission to the Company for conversion, exercise or exchange (as the case may be). No prior inability to convert this
      Note, or to issue shares of Common Stock, pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of convertibility. For purposes of this paragraph,
      beneficial ownership and all determinations and calculations (including, without limitation, with respect to calculations of percentage ownership) shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
      promulgated thereunder. The provisions of this paragraph shall be implemented in a manner otherwise than in strict conformity with the terms of this paragraph to correct this paragraph (or any portion hereof) which may be defective or inconsistent
      with the intended Maximum Percentage beneficial ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such Maximum Percentage limitation. The limitations contained in this paragraph
      shall apply to a successor Holder of this Note. The holders of Common Stock shall be third party beneficiaries of this paragraph and the Company may not waive this paragraph without the consent of holders of a majority of its Common Stock. For any
      reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding, including by virtue of any prior
      conversion or exercise of convertible or exercisable securities into Common Stock, including, without limitation, pursuant to this Note or securities issued pursuant to the Purchase Agreement.

    

    

    
      3

      
        

    

    

    

    (ii) Principal Market Regulation. Unless permitted by the applicable
      rules and regulations of the Principal Market, the Company shall not issue any shares of Common Stock upon conversion of this Note if the issuance of such shares of Common Stock would exceed the aggregate number of shares of Common Stock which the
      Company may issue upon exercise or conversion (as the case may be) of the Note without breaching the Company’s obligations under the rules or regulations of the Principal Market (the number of shares which may be issued without violating such rules
      and regulations, the “Exchange Cap”). Notwithstanding the foregoing, such limitation shall not apply in the event that the Company (A) obtains the approval of its stockholders as
      required by the applicable rules of the Principal Market for issuances of shares of Common Stock in excess of such amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall be
      reasonably satisfactory to the Holder. In the event that any Holder shall sell or otherwise transfer any of such Holder’s Note, the Exchange Cap restrictions set forth herein shall continue to apply to the Note and such transferee.

    

    

    (iii) No Conversion until Sufficient Authorized and Unissued Shares Available. 

      Notwithstanding anything herein to the contrary, this Note shall not be convertible into shares of Common Stock of the Company until such time as the Company’s authorized and unissued shares of Common Stock are at a number sufficient to permit the
      conversion of this Note and the conversion or exercise, as applicable, of all other outstanding securities of the Company convertible into or exercisable for shares of Common Stock of the Company.

    

    

                                           (e) Disputes. In the event of a dispute as to the number of shares of
      Common Stock issuable to the Holder in connection with a conversion of this Note, the Company shall issue to the Holder the number of shares of Common Stock not in dispute and resolve such dispute in accordance with Section 19.

    

    

    (4) [RESERVED.]

    

    

    (5) RIGHTS UPON EVENT OF DEFAULT.

    

    

                                          (a) Event of Default. Each of the following events shall constitute an
      “Event of Default”; provided, however, that, except in the case of the Events of Default listed in
      Sections 5(a)(i), 5(a)(ix) or 5(a)(xxiv) below, the Company shall have five (5) Business Days after notice of default from the Holder to cure such Event of Default unless a lesser number of days is required pursuant to the provisions of this Section
      5.

    

    

    
      4

      
        

    

    (i) Failure to Pay Principal or Interest. The Company fails to pay
      the Principal or Interest due at the Disbursement Maturity Date, liquidated damages and other amounts thereon when due on the Note whether at maturity, upon acceleration or otherwise.

    

    

    (ii) Conversion and the Shares. The Company (i) fails to issue
      Conversion Shares to the Holder (or announces or threatens in writing that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of the Note, (ii) fails to transfer
      or cause its transfer agent to transfer (issue) (electronically or in certificated form) any certificate for the Conversion Shares issuable to the Holder upon conversion of or otherwise pursuant to the Note as and when required by the Note, or (iii)
      the Company directs its transfer agent not to transfer or delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for the Conversion Shares issuable to the Holder upon
      conversion of or otherwise pursuant to the Note as and when required by the Note, or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to
      withdraw any stop transfer instructions in respect thereof) on any certificate for any Conversion Shares issued to the Holder upon conversion of or otherwise pursuant to the Note as and when required by the Note (or makes any written announcement,
      statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure shall continue uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in
      writing) for five (5) Business Days after the Holder shall have delivered a Conversion Notice. It is an obligation of the Company to remain current in its obligations to its transfer agent. It shall be an Event of Default of the Note, if a conversion
      of the Note is delayed, hindered or frustrated due to a balance owed by the Company to its transfer agent. If at the option of the Holder, the Holder advances any funds to the Company’s transfer agent in order to process a conversion, such advanced
      funds shall be paid by the Company to the Holder within forty-eight (48) hours of a demand from the Holder. If Borrower is unable to do so, they shall have an opportunity to cure within five (5) Business Days.

    

    

    (iii) Breach of Agreements and Covenants. The Company breaches any
      material agreement, covenant or other material term or condition contained in the Transaction Documents, and such breach results in a Material Adverse Effect on the business or assets of the Company; for the avoidance of doubt a failure of the
      Company to file a registration statement by the  “Filing Date” and have the same declared effective by the “Effectiveness Date” as provided in the Registration Rights Agreement will constitute a breach of a material agreement that results in a
      Material Adverse Effect on the business of the Company for purposes of this Note and the Purchase Agreement.

    

    

    (iv) Breach of Representations and Warranties. Any representation or
      warranty of the Company made in the Purchase Agreement or the Note, or in any agreement, statement or certificate given in writing pursuant hereto or in connection herewith or therewith shall be false or misleading in any material respect when made
      and the breach of which has (or with the passage of time will have) a Material Adverse Effect on the rights of the Holder with respect to the Note or the Purchase Agreement. In the event of such a breach, the Company shall have an opportunity to cure
      within five (5) Business Days.

    

    

    (v) Receiver or Trustee. The Company or any subsidiary of the Company
      shall make an assignment for the benefit of creditors, or apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such a receiver or trustee shall otherwise be appointed. Under
      such circumstances, the Company shall have an opportunity to cure within sixty (60) calendar days.

     

    

    
      5

      
        

    

    (vi) Judgments. Any money judgment, writ or similar process shall be
      entered or filed against the Company or any subsidiary of the Company or any of its property or other assets for more than $1,000,000 and shall remain unvacated, unbonded or unstayed for a period of twenty (20) calendar days unless otherwise
      consented to by the Holder, which consent will not be unreasonably withheld, conditioned or delayed.

    

    

    (vii) Bankruptcy. Bankruptcy, insolvency, reorganization or
      liquidation proceedings or other proceedings, voluntary or involuntary, for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Company or any subsidiary of the Company. Under such circumstances,
      the Company shall have an opportunity to cure within sixty (60) calendar days.

    

    

    (viii) Delisting or Trading of Common Stock. The Company shall fail
      to maintain the listing or quotation of its Common Stock minimally on a Trading Market, which shall include the OTC pink sheets pro-rata based on the entire amount raised.

    

    

    (ix) Failure to Comply with the Exchange Act.  After the date hereof,
      the Company shall (a) fail to file all Form 10-Qs and Form 10-Ks within the time periods required by the Exchange Act or (b) cease to be subject to the reporting requirements of the Exchange Act.

    

    

    (x) Liquidation. Any dissolution, liquidation, or winding up of the
      Company or any substantial portion of its business or assets.

    

    

    (xi) Cessation of Operations. Any cessation of operations by the
      Company or the Company admits it is otherwise generally unable to pay its debts as such debts become due; provided, however, that any disclosure of the Company’s ability to continue as a “going concern” shall not be an admission that the Company
      cannot pay its debts as they become due.

    

    

    (xii) Reverse Stock Split.  The Company fails to reduce its
      outstanding shares via a reverse stock split to provide a number of authorized and unissued shares of Common Stock sufficient to permit the conversion of this Note and the conversion or exercise, as applicable, of all other outstanding securities of
      the Company convertible into or exercisable for shares of Common Stock of the Company on or before December 31, 2022.

    

    

    (xiii) Depository Trust Company (“DTC”) “Chill”. The DTC places a
      “chill” (i.e., a restriction placed by DTC on one or more of DTC’s services, such as limiting a DTC participant’s ability to make a deposit or withdrawal of the security at DTC) on any of the Company’s securities. In the event of such a breach, the
      Company shall have an opportunity to cure within twenty (20) Business Days.

    

    

    (xiv) [Reserved.]

    

    

    (xv) Default under Transaction Documents or Other Material Agreement.
      Other than those defaults or events of default previously disclosed by the Company in its SEC Reports (including any defaults and events of default that are continuing on and after the date hereof), including information contained or incorporated by
      reference therein as of the date hereof, a default or event of default (subject to any grace or cure period provided in the applicable agreement, document or instrument) shall occur under any Transaction Document or material agreement (which shall
      include, without limitation, all agreements filed with the SEC Reports), lease, document or instrument to which the Company or any Subsidiary is obligated and is identified in the Company’s Form 10-K or other Exchange Act filings, which results in a
      Material Adverse Effect.

    

    

    
      6

      
        

    

    (xvi) [Reserved.]

    

    

    (xvii) [Reserved.]

    

    

    (xviii) Failure to Meet the Requirements under Rule 144. The Company
      does not meet the current public information requirements under Rule 144.

    

    

    (xix) Failure to Maintain Intellectual Property. The failure by the
      Company or any material Subsidiary to maintain any material intellectual property rights, personal, real property, equipment, leases or other assets which are necessary to conduct its business (whether now or in the future) and such breach is not
      cured with twenty (20) calendar days after written notice to the Company from the Holder.

    

    

    (xx) Trading Suspension. An SEC or judicial stop trade order or
      suspension from a Trading Market.

    

    

    (xxi) Restatement of Financial Statements. The restatement after the
      date hereof of any financial statements filed by the Company with the SEC for any date or period from two years prior to the Issuance Date and until this Note is no longer outstanding, if the result of such restatement would, by comparison to the
      unrestated financial statements, have constituted a Material Adverse Effect. For the avoidance of doubt, any restatement related to new accounting pronouncements shall not constitute a default under this Section.

    

    

    (xxii) [Reserved.]

    

    

    (xxiii) Invalidity or Unenforceability of Transaction Documents. Any
      material provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to be valid and binding on or enforceable against the Company, or the validity or enforceability thereof shall be
      contested by the Company, or a proceeding shall be commenced by the Company or any governmental authority having jurisdiction over the Company or the Holder, seeking to establish the invalidity or unenforceability thereof, or the Company shall deny
      in writing that it has any liability or obligation purported to be created under any Transaction Document.

    

    

    (xxiv) Effective Registration Statement. Failure to comply with the
      Registration Rights Agreement or Purchase Agreement.

    

    

                                            (b) Redemption Right. At any time after the Holder becoming aware of
      an Event of Default, the Holder may require the Company to redeem (an “Event of Default Redemption”) all or any portion of this Note by delivering written notice thereof (the “Event of Default Redemption Notice”) to the Company, which Event of Default Redemption Notice shall indicate the portion of this Note the Holder is electing to require the Company to
      redeem and the date of such Event of Default Redemption (the “Event of Default Redemption Date”). Each portion of this Note subject to redemption by the Company pursuant to this
      Section 5(b) shall be redeemed by the Company in cash by wire transfer of immediately available funds at a price equal to Principal plus accrued and unpaid Interest calculated from the Event of Default at the Default Interest Rate (the “Event of Default Redemption Price”) together with liquidated damages of $250,000 pro-rata based on the entire
      amount raised plus an amount in cash equal to 1% of the Event of Default Redemption Price for each 30 day period during which redemptions fail to be made with a cap at 5%. Redemptions required by this Section 5(b) shall be made in accordance with the
      provisions of Section 10. To the extent an Event of Default Redemption is deemed or determined by a court of competent jurisdiction to be a prepayment of the Note by the Company, such redemption shall be deemed to be a voluntary prepayment.
      Notwithstanding anything to the contrary in this Section 5, but subject to Section 3(b)(ii) and 3(d), until the Event of Default Redemption Price (together with any interest thereon) is paid in full, the Conversion Amount submitted for redemption
      under this Section 5(b) (together with any interest thereon) may be converted, in whole or in part, by the Holder into Common Stock pursuant to Section 3. The parties hereto agree that in the event of the Company’s redemption of any portion of the
      Note under this Section 5(b), the Holder’s damages would be uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty of the availability of a suitable substitute investment opportunity
      for the Holder. Accordingly, any Event of Default Redemption Price due under this Section 5(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of the Holder’s actual loss of its investment opportunity and not as a
      penalty.

    
      7

      
        

    

    

    

    (6) RIGHTS UPON FUNDAMENTAL TRANSACTION. If, at any time while this
      Note is outstanding, the Company effects a Fundamental Transaction, then, upon any subsequent conversion of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion
      immediately prior to the occurrence of such Fundamental Transaction, the same kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately
      prior to such Fundamental Transaction, the holder of one (1) share of Common Stock (the “Alternate Consideration”). For purposes of any such conversion, the determination of the Conversion
      Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one (1) share of Common Stock in such Fundamental Transaction, and the Company shall apportion the
      Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
      to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Note following such Fundamental Transaction. To the extent necessary to effectuate
      the foregoing provisions, any Successor Entity or Successor Entities to the Company or surviving entity in such Fundamental Transaction shall issue to the Holder a new Note consistent with the foregoing provisions and evidencing the Holder’s right to
      convert such Note into Alternate Consideration. The terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such Successor Entity or Successor Entities to comply with the provisions of this
      Section 6 and insuring that this Note (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction.

     

    

    (7) DISTRIBUTION OF ASSETS; RIGHTS UPON ISSUANCE OF PURCHASE RIGHTS AND OTHER CORPORATE EVENTS.

    

    

                                       (a) Distribution of Assets. If the Company shall declare or make any
      dividend or other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of Common Stock, by way of return of capital or otherwise (including without limitation, any distribution of cash, stock or other
      securities, property, options, evidence of Indebtedness or any other assets by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the “Distributions”), then the Holder will be entitled to such Distributions as if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without taking into account
      any limitations or restrictions on the convertibility of this Note) immediately prior to the date on which a record is taken for such Distribution or, if no such record is taken, the date as of which the record holders of Common Stock are to be
      determined for such Distribution and the portion of such Distribution shall be held in abeyance for the Holder until such time or times as its right thereto would not result in the Holder and its Affiliates and Attribution Parties exceeding the
      Maximum Percentage, at which time or times the Holder shall be granted such rights (and any rights under this Section 7(a) on such initial rights or on any subsequent such rights to be held similarly in abeyance) to the same extent as if there had
      been no such limitation.

    

    

    
      8

      
        

    

                                           (b) Purchase Rights. If at any time the Company grants, issues or
      sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common Stock (the “Purchase
        Rights”), then the Holder will be entitled to acquire or receive, as applicable, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of
      shares of Common Stock acquirable upon complete conversion of this Note (without taking into account any limitations or restrictions on the convertibility of this Note) immediately prior to the date on which a record is taken for the grant, issuance
      or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder and its Affiliates and
      Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such
      Purchase Right (and beneficial ownership) to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time or times as its right thereto would not result in the Holder and its Affiliates and Attribution
      Parties exceeding the Maximum Percentage, at which time or times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right to be held similarly in
      abeyance) to the same extent as if there had been no such limitation).

    

    

                                           (c) Other Corporate Events. In addition to and not in substitution
      for any other rights hereunder, prior to the occurrence or consummation of any Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities, cash, assets or other property with respect to or in
      exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to ensure that, and any applicable Successor Entity or Successor Entities
      shall ensure that, and it shall be a required condition to the occurrence or consummation of such Corporate Event that, the Holder will thereafter have the right to receive upon conversion of this Note at any time after the occurrence or consummation
      of the Corporate Event, shares of Common Stock or capital stock of the applicable Successor Entity or Successor Entities or, if so elected by the Holder, cash in lieu of the shares of Common Stock (or other securities, cash, assets or other property)
      purchasable upon the conversion of this Note prior to such Corporate Event, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights and any shares of Common Stock)
      which the Holder would have been entitled to receive upon the occurrence or consummation of such Corporate Event or the record, eligibility or other determination date for the event resulting in such Corporate Event, had this Note been converted
      immediately prior to such Corporate Event or the record, eligibility or other determination date for the event resulting in such Corporate Event (without regard to any limitations on conversion of this Note). Provision made pursuant to the preceding
      sentence shall be in a form and substance satisfactory to the Holder. The provisions of this Section 7 shall apply similarly and equally to successive Corporate Events.

    

    

                                 (8)      RIGHTS UPON ISSUANCE OF OTHER SECURITIES.

    

    

                                          (a) Adjustment of Conversion Price upon Subdivision or Combination of Common
          Stock. If the Company at any time on or after the Issuance Date subdivides (by any stock split, stock dividend, recapitalization or otherwise), one or more classes of its outstanding shares of Common Stock into a greater number of
      shares, the Conversion Price in effect immediately prior to such subdivision will be proportionately reduced; provided, however, that the Conversion Price pursuant to this Section 8(a) shall never be less than $0.01. If the Company at any time on or
      after the Issuance Date combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Conversion Price in effect immediately prior to such combination
      will be proportionately increased.

    

    

    
      9

      
        

    

                                          (b) Adjustment Upon Issuance of Shares of Common Stock. If and
      whenever on or after the date hereof, the Company issues or sells, or in accordance with this Section 8(b) is deemed to have issued or sold, any shares of Common Stock (including the issuance or sale of shares of Common Stock owned or held by or for
      the account of the Company, but excluding any Exempt Issuance issued or sold or deemed to have been issued or sold) for a consideration per share (the “New Issuance Price”) less
      than a price equal to the Conversion Price in effect immediately prior to such issue or sale or deemed issuance or sale (such Conversion Price then in effect is referred to as the “Applicable

        Price”) (the foregoing a “Dilutive Issuance”), then immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to the New Issuance
      Price; provided, however, that the Conversion Price pursuant to this Section 8(b) shall never be less than $0.01. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and consideration per share
      under this Section 8(b)), the following shall be applicable:

    

    

    (i) Issuance of Options. If the Company in any manner grants or sells
      any Options (other than Options that qualify as Exempt Issuances) and the lowest price per share for which one share of Common Stock is issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible
      Securities issuable upon exercise of any such Option is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such
      Option for such price per share. For purposes of this Section 8(b)(i), the “lowest price per share for which one share of Common Stock is issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible
      Securities issuable upon exercise of any such Option” shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the granting
      or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option and (y) the lowest exercise price set forth in such Option for which one share of Common
      Stock is issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option minus (2) the sum of all amounts paid or payable to the holder of such Option (or
      any other Person) upon the granting or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option plus the value of any other consideration received or
      receivable by, or benefit conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock or of such
      Convertible Securities upon the exercise of such Options or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities.

    

    

    
      10

      
        

    

    (ii) Issuance of Convertible Securities. If the Company in any manner
      issues or sells any Convertible Securities (other than Convertible Securities that qualify as Exempt Issuances) and the lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less
      than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale of such Convertible Securities for such price per share. For the purposes
      of this Section 8(b)(ii), the “lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof” shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any)
      received or receivable by the Company with respect to one share of Common Stock upon the issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security and (y) the lowest conversion price set forth
      in such Convertible Security for which one share of Common Stock is issuable upon conversion, exercise or exchange thereof minus (2) the sum of all amounts paid or payable to the holder of such Convertible Security (or any other Person) upon the
      issuance or sale of such Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated below, no further
      adjustment of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities, and if any such issue or sale of such Convertible Securities is made upon
      exercise for which adjustment of this Note has been or is to be made pursuant to other provisions of this Section 8(b)(ii), except as contemplated below, no further adjustment of the Conversion Price shall be made by reason of such issue or sale.

    

    

    (iii) Change in Option Price or Rate of Conversion. If the purchase
      or exercise price provided for in any Options, the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible into or
      exercisable or exchangeable for shares of Common Stock increases or decreases at any time, the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been in effect at such time
      had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of
      this Section 8(b)(iii), if the terms of any Option or Convertible Security that was outstanding as of the date of issuance of this Note are increased or decreased in the manner described in the immediately preceding sentence, then such Option or
      Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 8(b) shall be
      made if such adjustment would result in an increase of the Conversion Price then in effect.

    

    

    (iv) Calculation of Consideration Received. If any Option and/or
      Convertible Security is issued in connection with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the “Primary Security,”
      and such Option and/or Convertible Security, the “Secondary Securities”), together comprising one integrated transaction, the consideration per share of Common Stock with respect to such
      Primary Security shall be deemed to be equal to the difference of (x) the lowest price per share for which one share of Common Stock was issued in such integrated transaction (or was deemed to be issued pursuant to Section 8(b)(i) or 8(b)(ii) above,
      as applicable) solely with respect to such Primary Security, minus (y) with respect to such Secondary Securities, the fair market value of such Secondary Securities as agreed to by the Company and the Holder and absent such agreement by an
      independent, reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the
      Company.

    

    

    (c) Company Conversion Right and Adjustment of Conversion Price Upon Listing. 
        If the Company lists its shares of Common Stock on the Nasdaq Capital Market, then, upon the approval of the Board of Directors, all Principal and accrued and
        unpaid Interest under this Note shall automatically convert into Common Stock at the then effective Conversion Price.  Notwithstanding the foregoing, if, for the five (5) Trading Day period immediately prior
        to such approval by the Board of Directors, the average VWAP of the listed Common Stock (the “Post-Listing Threshold Price”) is less than $0.04 per share (as adjusted for any reverse stock
          split, stock split, dividend or other distribution, recapitalization or similar event with respect to the Common Stock that occurs after the date hereof), then the Conversion Price then in effect shall be reduced to the greater of (i) the
        Post-Listing Threshold Price and (ii) $0.01.

    

    

    
      11

      
        

    

    (d) Calculations. All calculations under this Section 8 shall be made to the nearest
      cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 8, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock
      (excluding any treasury shares of Company) issued and outstanding.

    

    

    (e) Notice to the Holder.

     

        

    (i) Adjustment to Conversion Price. Whenever the Conversion Price is
      adjusted pursuant to any provision of this Section 8, the Company shall provide to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment within two (2)
      Business Days of such event.

    

    

    (ii) Notice to Allow Conversion by Holder. If (A) Company shall
      declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all
      holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of
      the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other
      securities, cash or property or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be filed at each office or agency
      maintained for the purpose of conversion of this Note, and shall cause to be delivered to the Holder at its last address as it shall appear upon the Note Register, at least twenty (20) calendar days prior to the applicable record or effective date
      hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
      Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become
      effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
      consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.
      To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the SEC pursuant to a Current Report
      on Form 8-K. The Holder shall remain entitled to convert this Note during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

    

    

    (f) Voluntary Adjustment by Company. The Company may at any time during the term of this
      Note, with the prior written consent of each Holder so affected, reduce the then current Conversion Price to any amount and for any period of time deemed appropriate by the Board of Directors of the Company.

    

    

    
      12

      
        

    

    (9) NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will not,
      by amendment of its Articles of Incorporation, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the
      observance or performance of any of the terms of this Note, and will at all times in good faith carry out all of the provisions of this Note and take all action as may be required to protect the rights of the Holder of this Note.

    

    

    (10) REDEMPTIONS. In the case of a redemption, the Company shall deliver the Event of
      Default Redemption Price or the Optional Redemption Price to the Holder on or prior to the Event of Default Redemption Date or the Optional Redemption Date, respectively. The Company shall pay the applicable Event of Default Redemption Price or
      Optional Redemption Price to the Holder in cash by wire transfer of immediately available funds pursuant to wire instructions provided by the Holder in writing to the Company on the applicable due date. In the event of a redemption of less than all
      of the Conversion Amount of this Note, the Company shall promptly cause to be issued and delivered to the Holder a new Note (in accordance with Section 14(d)) representing the outstanding Principal which has not been redeemed and any accrued Interest
      on such Principal which shall be calculated as if no Redemption Notice had been delivered. In the event that the Company does not pay the applicable Redemption Price to the Holder within the time period required, at any time thereafter and until the
      Company pays such unpaid Redemption Price in full, the Holder shall have the option, in lieu of redemption, to require the Company to promptly return to the Holder all or any portion of this Note representing the Conversion Amount that was submitted
      for redemption and for which the applicable Redemption Price has not been paid. Upon the Company’s receipt of such notice, (x) the applicable Redemption Notice shall be null and void with respect to such Conversion Amount, (y) the Company shall
      immediately return this Note, or issue a new Note (in accordance with Section 14(d)) to the Holder representing such Conversion Amount to be redeemed and (z) the Conversion Price of this Note or such new Notes shall be adjusted to the lesser of (A)
      the Conversion Price as in effect on the date on which the applicable Redemption Notice is voided and (B) the lowest Closing Bid Price of the Common Stock during the period beginning on and including the date on which the applicable Redemption Notice
      is delivered to the Company and ending on and including the date on which the applicable Redemption Notice is voided; provided, however, that in no event shall the Conversion Price be a price less than the Market Price.

    

    

    (11) VOTING RIGHTS. The Holder shall have no voting rights as the holder of this Note,
      except as required by law and as expressly provided in this Note.

    

    

    (12) COVENANTS.

     

        

    (a) Incurrence of Indebtedness. So long as this Note is outstanding, the Company shall
      not, and the Company shall not permit any of its Subsidiaries to, directly or indirectly, incur or guarantee, assume or suffer to exist any Indebtedness, other than Permitted Indebtedness.

    

    

    (b) Existence of Liens. So long as this Note is outstanding, the Company shall not, and
      the Company shall not permit any of its Subsidiaries to, directly or indirectly, allow or suffer to exist any Liens other than Permitted Liens.

    

    

    (c) Change in Nature of Business. The Company shall not make, or permit any of its
      Subsidiaries to make, any change in the nature of its business as described in the Company's most recent Annual Report filed on Form 10-K with the SEC. The Company shall not modify its corporate structure or purpose.

    

    

    (d) [Reserved.]

    

    

    
      13

      
        

    

    (e) Preservation of Existence, Etc. The Company shall maintain and preserve, and cause
      each of its Subsidiaries to maintain and preserve, its existence, rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and in good standing in each jurisdiction in which the character of
      the properties owned or leased by it or in which the transaction of its business makes such qualification necessary.

    

    

    (f) Maintenance of Properties, Etc. The Company shall maintain and preserve, and cause
      each of its Subsidiaries to maintain and preserve, all of its properties which are necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear and tear excepted, and comply, and cause each of its
      Subsidiaries to comply, at all times with the provisions of all leases to which it is a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.

    

    

    (g) Maintenance of Insurance. The Company shall maintain, and cause each of its
      Subsidiaries to maintain, insurance with responsible and reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard, rent and business interruption insurance) with respect to its properties
      (including all real properties leased or owned by it) and business, in such amounts and covering such risks as is required by any governmental authority having jurisdiction with respect thereto or as is carried generally in accordance with sound
      business practice by companies in similar businesses similarly situated.

    

    

    (h) Transactions with Affiliates. The Company shall not, nor shall it permit any of its
      Subsidiaries to, enter into, renew, extend or be a party to, any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer or exchange of property or assets of any kind or the rendering of
      services of any kind) with any Affiliate, except for Permitted Indebtedness or in the ordinary course of business in a manner and to an extent consistent with past practice and necessary or desirable for the prudent operation of its business, for
      fair consideration and on terms no less favorable to it or its Subsidiaries than would be obtainable in a comparable arm’s length transaction with a Person that is not an Affiliate thereof.

    

    

    (i) Corporate Changes. The Company shall not change its corporate name, legal form or
      jurisdiction of formation without twenty (20) calendar days’ prior written notice to Holder. The Company shall not enter into or be party to a Fundamental Transaction unless in accordance with Section 6 hereof. The Company shall not relocate its
      chief executive office or its principal place of business unless it has provided prior written notice to the Holder.

    

    

    (j) [Reserved.]

    

    

    (k) Charter Amendments.  The Company shall not amend its charter documents, including,
      without limitation, its Articles of Incorporation and Bylaws, in any manner that materially and adversely affects any rights of the Holder.

    

    

    (l) Repurchase. The Company shall not repay, repurchase or offer to repay, repurchase or
      otherwise acquire more than a de minimis number of shares of its Common Stock or common stock equivalents other than as to the
      Conversion Shares as permitted or required under the Transaction Documents.

    

    

    (m) Redemption. The Company shall not redeem, defease, repurchase, repay or make any
      payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other than the Note if on a
      pro-rata basis), whether by way of payment in respect of principal of (or premium, if any) or interest on, such Indebtedness; the foregoing restriction shall not apply to Permitted Indebtedness except upon the occurrence of an Event of Default.

    

    

    
      14

      
        

    

    (n) Declaration. The Company shall not declare or make any dividend or other
      distribution of its assets or rights to acquire its assets to holders of shares of Common Stock, by way of return of capital or otherwise including, without limitation, any distribution of cash, stock or other securities, property or options by way
      of a dividend, spin-off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction.

    

    

    (13) TRANSFER. This Note and any shares of Common Stock issued upon conversion of this
      Note may be offered, sold, assigned or transferred according to the Purchase Agreement.

    

    

    (14) REISSUANCE OF THIS NOTE.

    

    

    (a) Transfer. If this Note is to be transferred, the Holder shall instruct the Company
      who the new Holder will be, and this Note will be automatically cancelled.   The Company will issue and deliver the new Note within two (2) Business Days of such notice.

    

    

    (b) Lost, Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably
      satisfactory to the Company of the loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary form and, in the case of mutilation,
      upon surrender and cancellation of this Note, the Company shall execute and deliver to the Holder a new Note (in accordance with Section 14(d)) representing the then outstanding Principal amount of the Note.

    

    

    (c) Note Exchangeable for Different Denominations. This Note is exchangeable, upon the
      surrender hereof by the Holder at the principal office of the Company, for a new Note or Notes (in accordance with Section 14(d)) representing in the aggregate the outstanding Principal of this Note, and each such new Note will represent such portion
      of such outstanding Principal as is designated by the Holder at the time of such surrender.

    

    

    (d) Issuance of New Notes. Whenever the Company is required to issue a new Note pursuant
      to the terms of this Note, such new Note (i) shall be of like tenor with this Note, (ii) shall represent, as indicated on the face of such new Note, the Principal remaining outstanding (or in the case of a new Note being issued pursuant to Section
      14(a) or Section 14(c), the Principal designated by the Holder which, when added to the Principal represented by the other new Notes issued in connection with such issuance, does not exceed the Principal remaining outstanding under this Note
      immediately prior to such issuance of new Notes), (iii) shall have an issuance date, as indicated on the face of such new Note, which is the same as the Issuance Date of this Note, (iv) shall have the same rights and conditions as this Note, and (v)
      shall represent accrued and unpaid Interest on the Principal and Interest of this Note, from the Issuance Date.

    

    

    (15) REMEDIES, CHARACTERIZATIONS, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The
      remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note and any of the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive
      relief), and nothing herein shall limit the Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Note. Amounts set forth or provided for herein with respect to payments, conversion,
      redemption and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company
      acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened
      breach, the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.

    

    

    
      15

      
        

    

    (16) PAYMENT OF COLLECTION, ENFORCEMENT AND OTHER COSTS. If (a) this Note is placed in
      the hands of an attorney for collection or enforcement or is collected or enforced through any legal proceeding or the Holder otherwise takes action to collect amounts due under this Note or to enforce the provisions of this Note or (b) there occurs
      any bankruptcy, reorganization, receivership of the Company or other proceedings affecting Company creditors’ rights and involving a claim under this Note, then the Company shall pay the reasonable and documented out-of-pocket costs and expenses
      incurred by the Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including, but not limited to, attorneys’ fees and disbursements.

    

    

    (17) CONSTRUCTION; HEADINGS. This Note shall be deemed to be jointly drafted by the
      Company and the Holder and shall not be construed against any person as the drafter hereof. The headings of this Note are for convenience of reference and shall not form part of, or affect the interpretation of, this Note.

    

    

    (18) FAILURE OR INDULGENCE NOT WAIVER. No failure or delay on the part of the Holder in
      the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or
      privilege.

    

    

    (19) DISPUTE RESOLUTION. In the case of a dispute as to the determination of the
      arithmetic calculation of the Conversion Rate, the Conversion Price or any Redemption Price, the Company shall submit the disputed determinations or arithmetic calculations via facsimile or electronic mail within one (1) Business Day of receipt, or
      deemed receipt, of the Conversion Notice or Redemption Notice or other event giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation within two (2)
      Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2) Business Days submit via facsimile or electronic mail the disputed arithmetic calculation of the Conversion
      Rate, Conversion Price or any Redemption Price to an independent, outside accountant, selected by the Holder and approved by the Company, such approval not to be unreasonably withheld, conditioned or delayed. The Company, at the Company’s expense,
      shall cause the accountant to perform the determinations or calculations and notify the Company and the Holder of the results no later than five (5) Business Days from the time it receives the disputed determinations or calculations. Such
      accountant’s determination or calculation shall be binding upon all parties absent demonstrable error.

    

    

    (20) NOTICES; PAYMENTS.

    

    

    (a) Notices. All notices, demands, requests, consents, approvals, and other
      communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered
      by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, facsimile, or electronic mail, addressed as set forth below or to such other address as such party shall have specified most recently by written
      notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the
      address or number designated below (if delivered on a Business Day during normal business hours where such notice is to be received), or the first Business Day following such delivery (if delivered other than on a Business Day during normal business
      hours where such notice is to be received), or (b) upon receipt, when sent by electronic mail (provided confirmation of transmission is electronically generated and keep on file by the sending party), or (c) on the second Business Day following the
      date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be: (i) if to the Company, to: SANUWAVE Health,
      Inc., 11495 Valley View Road, Eden Prairie, MN 55344, Attn: Kevin Richardson, Email: kevin.richardson@sanuwave.com, and (ii) if to the Holder, to the address and email address indicated in the Purchase Agreement. Without limiting the generality of
      the foregoing, the Company shall give written notice to the Holder (i) immediately upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and (ii) at least twenty (20)
      calendar days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common Stock, (B) with respect to any pro rata subscription offer to holders of Common Stock or (C) for
      determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction with such notice being provided to the
      Holder.

    

    

    
      16

      
        

    

    (b) Payments. Whenever any payment of cash is to be made by the Company to any Person
      pursuant to this Note, such payment shall be made in lawful money of the United States of America by a check drawn on the account of the Company and sent via overnight courier service to such Person at such address as previously provided to the
      Company in writing; provided, that the Holder may elect to receive a payment of cash via wire transfer of immediately available funds by providing the Company with prior written notice
      setting out such request and the Holder’s wire transfer instructions. Whenever any amount expressed to be due by the terms of this Note is due on any day, which is not a Business Day, the same shall instead be due on the next succeeding day, which is
      a Business Day.

    

    

    (21) CANCELLATION. After all Principal, accrued Interest and other amounts at any time
      owed on this Note have been paid in full, this Note shall automatically be deemed canceled, shall be surrendered to the Company for cancellation and shall not be reissued.

    

    

    (22) WAIVER OF NOTICE. To the extent permitted by law, the Company hereby waives demand,
      notice, protest and all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Note.

    

    

    (23) GOVERNING LAW; JURISDICTION; JURY TRIAL. All questions concerning the construction,
      validity, enforcement and interpretation of this Note shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. The Company agrees that
      all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Note (whether brought against the Company, the Holder or their respective affiliates, directors, officers, shareholders, employees
      or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, County of New York. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of
      New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or
      proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company hereby irrevocably waives personal service of
      process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to it at the address in effect for notices to it under
      the Purchase Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by
      law. If the Company or a Holder shall commence an action or proceeding to enforce any provisions of the Note, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable and documented
      out-of-pocket attorneys’ fees and other reasonable and documented out-of-pocket costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE COMPANY KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
        IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

    

    

    
      17

      
        

    

    (24) SEVERABILITY. If any provision of this Note is prohibited by law or otherwise
      determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable,
      and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Note so long as this Note as so modified continues to express, without material change, the original intentions of the parties
      as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization
      of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as
      possible to that of the prohibited, invalid or unenforceable provision(s).

    

    

    (25) DISCLOSURE. Upon receipt or delivery by the Company of any notice in accordance with
      the terms of this Note, unless the Company has in good faith determined that the matters relating to such notice do not constitute material, nonpublic information relating to the Company or its Subsidiaries, the Company shall within one (1) Business
      Day after any such receipt or delivery publicly disclose such material, nonpublic information on a Current Report on Form 8-K or otherwise. In the event that the Company believes that a notice contains material, nonpublic information relating to the
      Company or its Subsidiaries, the Company so shall indicate to such Holder contemporaneously with delivery of such notice, and in the absence of any such indication, the Holder shall be allowed to presume that all matters relating to such notice do
      not constitute material, nonpublic information relating to the Company or its Subsidiaries.

    

    

    (26) CERTAIN DEFINITIONS. For purposes of this Note, the following terms shall have the
      following meanings:

    

    

    (a) “Affiliate” means, with respect to any Person, any other Person that
      directly or indirectly controls, is controlled by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a Person means the power directly or indirectly either to vote 10% or more of the
      stock having ordinary voting power for the election of directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.

    

    

    (b) “Attribution Parties” means, collectively, the following Persons and
      entities: (i) any investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed or advised by the Holder’s investment manager or any of its
      Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (iv) any other Persons
      whose beneficial ownership of the Common Stock would or could be aggregated with the Holder and the other Attribution Parties for purposes of Section 13(d) of the Exchange Act. For clarity, the purpose of the foregoing is to subject collectively the
      Holder and all other Attribution Parties to the Maximum Percentage.

    

    

    
      18

      
        

    

    (c) “Bloomberg” means Bloomberg L.P.

    

    

    (d) “Closing Date” shall have the meaning ascribed to such term in the
      Purchase Agreement.

    

    

    (e) “Closing Bid Price” means, for any security as of any date, the last
      closing bid price for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price, then the last bid price of such security
      prior to 4:00 p.m., New York Time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing bid price of such security on the principal securities exchange or
      trading market where such security is listed or quoted for trading as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price of such security in the over-the-counter market on the electronic bulletin board for such
      security as reported by Bloomberg, or, if no closing bid price is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the OTC Link or “pink
      sheets” by OTC Markets Group Inc. (formerly Pink OTC Markets Inc.). If the Closing Bid Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price of such security on such date shall be the fair
      market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to Section 19. All such determinations
      shall be appropriately adjusted for any stock dividend, reverse stock split, stock split, stock combination, reclassification or similar transaction during the applicable calculation period.

    

    

    (f) “Common Stock” the common stock of the Company, par value $0.001 per
      share, and any other class of securities into which such securities may hereafter be reclassified or changed.

    

    

    (g) “Convertible Securities” means any stock or securities (other than
      Options) directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock.

    

    

    (h) “Default Interest Rate” means 20.0% per annum.

    

    

    (i) “Disbursement Maturity Date” means the date that is twelve (12) months
      from the date hereof.

    

    

    (j)  “Equity Interests” means (a) all shares of capital stock (whether
      denominated as common capital stock or preferred capital stock), equity interests, beneficial, partnership or membership interests, joint venture interests, participations or other ownership or profit interests in or equivalents (regardless of how
      designated) of or in a Person (other than an individual), whether voting or non-voting and (b) all securities convertible into or exchangeable for any of the foregoing and all warrants, options or other rights to purchase, subscribe for or otherwise
      acquire any of the foregoing, whether or not presently convertible, exchangeable or exercisable.

    

    

    (k) “Exchange Act” means the Securities Exchange Act of 1934, as amended, and
      the rules and regulations promulgated thereunder.

    

    

    
      19

      
        

    

    (l) “Fundamental Transaction” means (A) that the Company shall, directly or
      indirectly, including through Subsidiaries, Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Subject Entity, or (ii) sell, assign,
      transfer, convey or otherwise dispose of in excess of 30% of the properties or assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation S-X) to one or more Subject Entities, or (iii) make, or allow one or
      more Subject Entities to make, or allow the Company to be subject to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders of at least either (x)
      50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities making or party to,
      such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of Common Stock such that all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange
      offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the Exchange Act) of at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock purchase agreement or other business combination (including,
      without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby such Subject Entities, individually or in the aggregate, acquire, either (x) at least 50% of the outstanding shares
      of Common Stock, (y) at least 50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock purchase
      agreement or other business combination were not outstanding; or (z) such number of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the Exchange Act) of at least 50% of
      the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall, directly or indirectly, including through Subsidiaries, Affiliates or otherwise, in one or more related transactions
      allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, whether through acquisition, purchase, assignment,
      conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business combination, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner
      whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock, (y) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by
      all such Subject Entities as of the date hereof calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding
      shares of Common Stock or other equity securities of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring other stockholders of the Company to surrender their shares of Common
      Stock without approval of the stockholders of the Company or (C) directly or indirectly, including through Subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or
      transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to
      the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the intended treatment of such instrument or transaction.

    

    

    (m) “GAAP” means United States generally accepted accounting principles,
      consistently applied.

    

    

    (n) “Group” means a “group” as that term is used in Section 13(d) of the
      Exchange Act and as defined in Rule 13d-5 thereunder.

    

    

    (o) “Holiday” means a day other than a Business Day or on which trading does
      not take place on the Principal Market.

    

    

    (p) “Interest Rate” means 15.0% per annum.

    

    

    (q) “Market Price” shall mean the lowest Closing Bid Price on the Closing
      Date.

    

    

    
      20

      
        

    

    (r) “North Haven Note Purchase Agreement” means that certain Note and Warrant
      Purchase and Security Agreement, dated as of August 6, 2020, by and among NH Expansion Credit Fund Holdings LP, as agent, the holders from time to time party thereto, and the Company, as amended.

    

    

    (s) “Options” means any rights, warrants or options to subscribe for or
      purchase shares of Common Stock or Convertible Securities.

    

    

    (t) “Parent Entity” of a Person means an entity that, directly or indirectly,
      controls the applicable Person, including such entity whose common capital stock or equivalent equity security is quoted or listed on a Trading Market (or, if so elected by the Holder, any other market, exchange or quotation system), or, if there is
      more than one such Person or such entity, the Person or entity designated by the Holder or in the absence of such designation, such Person or such entity with the largest public market capitalization as of the date of consummation of the Fundamental
      Transaction.

    

    

    (u) “Permitted Indebtedness” means (i) Indebtedness evidenced by this Note;
      (ii) debt incurred to make acquisitions; (iii) trade payables incurred in the ordinary course of business consistent with past practice, (iv) unsecured indebtedness not in excess
      of $100,000 in the aggregate, (v) the Indebtedness set forth on Schedule 27(v) hereto; (vi) Indebtedness secured by Permitted Liens; (vii) Indebtedness with respect to surety bonds and
      similar obligations not to exceed $100,000, in each case incurred in the ordinary course of business; (viii) Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business; (ix) Indebtedness
      evidenced by the North Haven Note Purchase Agreement and the Notes (as defined therein) issued in connection therewith; (x) Indebtedness evidenced by the Permitted Notes, (xi) indebtedness incurred as a result of a loan made by any current officer,
      director, or employee of the Company, and (xii) indebtedness relating to a credit facility, revolving credit facility, asset backed loan, factoring arrangement or similar financing; provided that such facility, loan or financing is made on
      commercially reasonable terms and in any case does not involve the payment by the Company of interest at a rate in excess of twenty percent (20%) per year on amounts advanced to the Company thereunder

    

    

    (v) “Permitted Liens” means (i) any Lien for taxes not yet due or delinquent
      or being contested in good faith by appropriate proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business by operation of law with respect to a liability
      that is not yet due or delinquent, (iii) any Lien created by operation of law, such as materialmen's liens, mechanics’ liens and other similar liens, arising in the ordinary course of business with respect to a liability that is not yet due or
      delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (A) upon or in any equipment acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment or Indebtedness
      incurred solely for the purpose of financing the acquisition or lease of such equipment, or (B) existing on such equipment at the time of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon,
      and the proceeds of such equipment, (v) Liens incurred in connection with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clause (iv) above, provided that any extension, renewal or replacement Lien
      shall be limited to the property encumbered by the existing Lien and the principal amount of the Indebtedness being extended, renewed or refinanced does not increase, (vi) leases or subleases and licenses and sublicenses granted to others in the
      ordinary course of the Company’s business, not interfering in any material respect with the business of the Company and its Subsidiaries taken as a whole, (vii) Liens in favor of customs and revenue authorities arising as a matter of law to secure
      payments of custom duties in connection with the importation of goods, (viii) Liens arising from judgments, decrees or attachments in circumstances not constituting an Event of Default under Section 5(a)(vi), (ix) Liens listed on Schedule 27(v) hereto and (x) Liens to secure repayment of the North Haven Note Purchase Agreement and the Notes (as defined therein).

    

    

    
      21

      
        

    

    (w) “Permitted Notes” means (a) that certain Convertible Promissory Note, dated as of August 6, 2020, by and between the Company and Celularity Inc., a Delaware corporation, in the original principal amount of $4,000,000, (b) that certain
      Convertible Promissory Note, dated as of August 6, 2020, by and between the Company and HealthTronics, Inc., a Georgia corporation, in the original principal amount of $1,72,743, and (c) that certain Convertible Promissory Note, dated as of August 6,
      2020, by and between the Company and A. Michael Stolarski, in the original principal amount of $223,511.26.

    

    

    (x) “Principal Market” means the OTCQB tier of the OTC Markets or any
      successor principal Trading Market for the Common Stock.

    

    

    (y) “Redemption Dates” means, collectively, the Event of Default Redemption
      Dates, and the Optional Redemption Dates, each of the foregoing, individually, a Redemption Date.

    

    

    (z) “Redemption Notices” means, collectively, the Event of Default Redemption
      Notices, and the Optional Redemption Notices, each of the foregoing, individually, a Redemption Notice.

    

    

    (aa) “Related Fund” means, with respect to any Person, a fund or account
      managed by such Person or an Affiliate of such Person.

    

    

    (bb) “Rule 144” shall have the meaning ascribed to such term in the Purchase
      Agreement.

     

    

    (cc) “SEC” means the United States Securities and Exchange Commission.

    

    

    (dd) “Subject Entity” means any Person, Persons or Group or any Affiliate or
      associate of any such Person, Persons or Group.

    

    

    (ee) “Successor Entity” means one or more Person or Persons (or, if so
      elected by the Holder, the Company or Parent Entity) formed by, resulting from or surviving any Fundamental Transaction or one or more Person or Persons (or, if so elected by the Holder, the Company or the Parent Entity) with which such Fundamental
      Transaction shall have been entered into.

    

    

    (ff) “Trading Market” means any of the following markets or exchanges on
      which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to
      any of the foregoing).

    

    

    [Signature Page Follows]

     

    
      22

      
        

    

    IN WITNESS WHEREOF, the Company has caused this Note to be duly executed as of the Issuance Date set out above.

     

    	 	
            SANUWAVE HEALTH, INC.

          
	 	 
	 	
            By:

          	

          	 
	 	
            Name: Kevin A. Richardson II

          
	 	
            Title: CEO

          

     

    

    
      [Signature Page to Convertible Promissory Note]

    

     

    

    
      
        

    

    EXHIBIT I

     SANUWAVE HEALTH, INC.

    CONVERSION NOTICE

    

    

    Reference is made to the Future Advance Convertible Promissory Note (the “Note”) issued to
      [          ], a [          ], by SANUWAVE Health, Inc., a corporation organized under the laws of Nevada (the “Company”). In accordance with and pursuant to the Note, the
      undersigned hereby elects to convert the Conversion Amount (as defined in the Note) of the Note indicated below into common stock, par value $0.001 per share (the “Common Stock”),

      of the Company, as of the date specified below.

    

    

    	
            Date of Conversion:

          	 	 
	
             

            Aggregate Conversion Amount to be converted:

          	 

    

    

    Please confirm the following information:

    	
             

            Conversion Price:

          	 
	
             

            Number of shares of Common Stock to be issued:

          	 

    

    

    Please issue the Common Stock into which the Note is being converted in the following name and to the following address:

    

    

    	 	
            Issue to:

          	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	
             

            Electronic Mail:

          	 
	 	
             

            Authorization:

          	 
	 	 	
            By:

          	 
	 	 	 	
            Title:

          	 
	
             

            Dated:

          	 
	 	
            Account Number:

          	 
	 	
            (if electronic book entry transfer)

          
	 	
            Transaction Code Number:

          	 
	 	
            (if electronic book entry transfer)

          

     

    
      
        

    

    SCHEDULE 27(V)

    PERMITTED INDEBTEDNESS AND LIENS

    

    

    Permitted Indebtedness

    

    

    	

          	1.	
            Loan incurred by the Company under 15 U.S.C. 636(a)(36) (as added to the Small Business Act by Section 1102 of the CARES Act) in the original principal amount of Four Hundred Fifty Four Thousand
              Three Hundred Thirty Five Dollars ($454,335), as amended, restated, amended and restated, supplemented or otherwise modified from time to time.

          

    

    

    	

          	2.	
            Indebtedness under that certain Master Equipment Lease, dated as of January 19, 2018 (the “NFS Master Equipment
                Lease”), by and between NFS Leasing, Inc., a Massachusetts corporation, and the Company, as amended, restated, amended and restated, supplemented or otherwise modified from time to time.

          

    

    

    	

          	3.	
            Indebtedness under that certain Factoring Agreement (the “Goodman Factoring Agreement”), by and a Goodman
              Capital Finance, a division of Independent Bank, SANUWAVE, Inc., a Delaware corporation, and the Company, as amended, restated, amended and restated, supplemented or otherwise modified from time to time.

          

    

    

    	

          	4.	
            Indebtedness under (a) that certain Future Advance Convertible Promissory Note, dated as of September 3, 2021, by and between the Company and David S. Nagelberg 2003 Revocable Trust, in the original
              principal amount of $108,000, (b) that certain Future Advance Convertible Promissory Note, dated as of September 3, 2021, by and between the Company and Jeffrey Benton, in the original principal amount of $54,000, (c) that certain Future
              Advance Convertible Promissory Note, dated as of September 3, 2021, by and between the Company and Karl W. Brewer, in the original principal amount of $162,000, (d) that certain Future Advance Convertible Promissory Note, dated as of
              September 3, 2021, by and between the Company and LGH Investments, LLC, in the original principal amount of $108,000, and (d) that certain Future Advance Convertible Promissory Note, dated as of September 3, 2021, by and between the Company
              and Quick Capital, LLC, in the original principal amount of $108,000 (collectively, the “2021 Notes”).

          

    

    

    Permitted Liens

    

    

    	

          	1.	
            Liens securing obligations under the NFS Master Equipment Lease.

          

    	

          	2.	
            Liens securing obligations under the Goodman Factoring Agreement.

          

    	

          	3.	
            Liens securing obligations under the 2021 Notes.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]